Started laser refractive surgical procedure in 1992.
The SingLASIK Centre now offers refractive and LASIK services by 12 dedicated and skillful LASIK surgeons, who are fully committed to their patients.
SNEC embarks on research and medical trials. Since 2007, SNEC has participated in global clinical trials on Acufocus, a potential solution for presbyopia (“lau hua”).
SNEC promotes public health awareness. In 2007, SNEC pinpointed, contained and treated a new cause of inflammation after LASIK.
From October 2008, the SingLASIK Centre offers the following LASIK technology platforms:
singlasik/snec : AchIEVEments and Milestones
